Delivery Order SPE2DR25D2010-SPE2DR26F4ZEU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8.84K to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 2, 2025, with completion expected by December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,770.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit of use packaging). The contract was competitively awarded without set-aside provisions and is classified as a firm fixed price delivery order, with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,160.10 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,302.47 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,651.77 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 14, 2025, with a completion date of November 17, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $22,165.99, with an ultimate completion date of June 20, 2025. The contract utilizes no set-aside designation and represents a competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a delivery order valued at $5,823.97 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units. The contract, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a $9,338.49 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of December 9, 2025, and is performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement typical of DLA's ongoing medical supply operations. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,352.74 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZEUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,018.04 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports military healthcare programs globally by supplying a comprehensive range of pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent performance across multiple therapeutic domains, positioning the company as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems under the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 12/8/25 |